We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

RNA-Seq – News and Features

News

G3 Completes GLOBAL Study Patient Enrollment

Pilot data of single largest prospective pan-omic study to identify key biomarkers and central therapeutic targets for cardiovascular diseases.
News

Genisphere Awarded Patent for Whole Transcriptome Next Generation Sequencing

US patent granted for a novel strand-specific library preparation method.
News

GW Receives up to $14.6M to Develop Method for Characterizing Security Threats

The researchers are tasked with reducing to 30 days a process that can sometimes take years or even decades.
News

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Chooses Genedata Expressionist for Oncology Research

Leading clinical-research institute of the Robert Bosch Stiftung uses Genedata Expressionist for managing, processing, and interpreting clinical NGS data
News

Agilent Awards Grant for Translational Research in Cardiometabolic Disease

Dr. Christopher Newgard's team at Duke University use Agilent platforms to better understand disease mechanisms.
News

Emerging Models: MicroRNAs in jute

Jute (Corchorus spp.), an important fibre crop in South Asia is vulnerable to stem rot caused by Macrophomina phaseolina.
News

Defending Ourselves by Keeping ‘Junk DNA’ Quiet

By genome-wide mapping in two mutant cell lines, the Meehan lab shows that loss of DNA methylation is coincident with specific activation of the IAP endogenous retroposon and the appearance of virus like particles.
News

Charting the RNA Epigenome

In science, sometimes you need to dive deep to see the big picture.
News

Agilent Thought Leader Award Supports Dr. Junying Yuan, Chinese Academy of Sciences

Integrated biological research is accelerating drug development for neurodegenerative diseases.
News

International Fruit Pest Targeted by Genomic Research

The spotted wing drosophila is itself being targeted, thanks to groundbreaking genome sequencing.
Advertisement